Exelon (Rivastigmine) for Multiple Sclerosis

Overview
Exelon is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat mild to moderate dementia associated with Alzheimer’s disease. Exelon is sometimes prescribed off-label to treat cognitive symptoms associated with multiple sclerosis (MS). Exelon is also referred to by its drug name, rivastigmine.

Exelon is a cholinesterase inhibitor. Exelon is believed to work by slowing the breakdown of a neurotransmitter in the brain.

How do I take it?
Exelon should be taken exactly as prescribed.

Exelon comes in capsule, oral solution, and transdermal patch forms.

Side effects
The FDA-approved label for Exelon lists common side effects including nausea, vomiting and diarrhea.

Rare but serious side effects listed for Exelon include weight changes, sinus infections, gastrointestinal adverse events, dehydration, and allergic dermatitis.

For more details about this treatment, visit:

Exelon Prescribing Information — Novartis
https://www.accessdata.fda.gov/drugsatfda_docs/...

Multiple Sclerosis Center - Symptom Management — UCSF Neurology Clinical Programs
https://multiplesclerosis.ucsf.edu/education_an...